| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040655760 |
| P356 | DOI | 10.1186/CC11443 |
| P932 | PMC publication ID | 3580723 |
| P698 | PubMed publication ID | 22835335 |
| P5875 | ResearchGate publication ID | 230572114 |
| P2093 | author name string | Fang Li | |
| Qingyuan Zhan | |||
| Bing Sun | |||
| Lin Ding | |||
| Hangyong He | |||
| P2860 | cites work | Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease | Q28251330 |
| Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome | Q28264458 | ||
| Invasive aspergillosis in the intensive care unit | Q28306909 | ||
| Aspergillosis case-fatality rate: systematic review of the literature | Q31918085 | ||
| Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis | Q34514484 | ||
| Diagnosis of invasive bronchial-pulmonary aspergillosis in patients with chronic obstructive respiratory diseases | Q35559604 | ||
| Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study | Q35567147 | ||
| Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis | Q35789251 | ||
| Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature | Q37095685 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients | Q40572100 | ||
| Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis | Q40734608 | ||
| Disseminated aspergillosis in intensive care unit patients: an autopsy study | Q44392075 | ||
| Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China | Q44856161 | ||
| Invasive aspergillosis in patients with chronic obstructive pulmonary diseases | Q46589280 | ||
| Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis | Q47561157 | ||
| Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. | Q47799923 | ||
| Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. | Q51176004 | ||
| The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. | Q51191763 | ||
| Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. | Q51192216 | ||
| The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD). | Q54321109 | ||
| Aspergillosis | Q55951920 | ||
| Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
| Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients | Q63859727 | ||
| Risk of infectious complications in patients taking glucocorticosteroids | Q69561570 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam | Q81454293 | ||
| [Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases] | Q82259756 | ||
| Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases | Q84839346 | ||
| Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease | Q85178759 | ||
| P433 | issue | 4 | |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| aspergillosis | Q259626 | ||
| bronchoalveolar lavage | Q927148 | ||
| invasive pulmonary aspergillosis | Q54946623 | ||
| P304 | page(s) | R138 | |
| P577 | publication date | 2012-07-27 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study | |
| P478 | volume | 16 |
| Q38199771 | Aspergillus tracheobronchitis in critically ill patients with chronic obstructive pulmonary diseases |
| Q35142428 | Biomarkers for invasive aspergillosis: the challenges continue |
| Q38221673 | Current challenges in the microbiological diagnosis of invasive aspergillosis |
| Q47169634 | Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis |
| Q36886708 | Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study |
| Q40141118 | Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis. |
| Q38263533 | Fungal glycans and the innate immune recognition |
| Q64249065 | Galactomannan detection in bronchoalveolar lavage fluid corrected by urea dilution for the diagnosis of invasive pulmonary aspergillosis among nonneutropenic patients |
| Q47108135 | Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients. |
| Q42382713 | Improving diagnostic accuracy for invasive pulmonary aspergillosis in the intensive care unit |
| Q33911297 | Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case report and review of the literature |
| Q36307784 | Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria |
| Q37287794 | Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome |
| Q35575320 | Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients |
| Q35222097 | Phylogenetic analyses on the diversity of Aspergillus fumigatus sensu lato based on five orthologous loci |
| Q38549796 | Republished: The clinical spectrum of pulmonary aspergillosis |
| Q55281032 | Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial. |
| Q42382708 | The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients |
| Q38508539 | The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients |
| Q93376926 | Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment |
| Q64131454 | What’s new in invasive pulmonary aspergillosis in the critically ill |
Search more.